Form 4: Fulgent Genetics COO's Tax-Related Stock Disposition

Fulgent Genetics President and COO Jian Xie disposed of 4,353 shares of common stock to cover tax obligations related to RSU vesting.

Summary

• Jian Xie, President and COO of Fulgent Genetics, Inc. (FLGT), reported a disposition of 4,353 shares of common stock.
• The transaction occurred on October 26, 2025, with shares valued at $23.74 each.
• The shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs).
• These RSUs were assumed as part of the Agreement and Plan of Merger dated November 7, 2022.
• Following this transaction, Jian Xie directly beneficially owns 359,768 shares of common stock.
• Additionally, 220,816 shares are indirectly beneficially owned through The Hsieh Family Dynasty Trust, dated January 27, 2010, where Mr. Xie serves on the investment committee.

Sentiment

Score: 5

Explanation: The filing details a routine, non-discretionary transaction by an insider to cover tax liabilities associated with RSU vesting. This is a neutral event that does not reflect a change in the company's operational performance or the insider's investment conviction.

Negatives

• A reduction of 4,353 shares in direct beneficial ownership by a key executive, although for a non-discretionary tax purpose.

Future Outlook

NA

Management Comments

• The shares were withheld from the reporting person to satisfy tax withholding obligations that arose upon the vesting of certain restricted stock units.

Industry Context

This filing represents a routine insider transaction related to executive compensation and tax obligations, which is common across publicly traded companies. It does not provide specific insights into broader industry trends or competitive positioning beyond the company's internal compensation structure.

Related Party Transactions

• Jian Xie indirectly beneficially owns 220,816 shares through The Hsieh Family Dynasty Trust, dated January 27, 2010, where he serves on the investment committee. He disclaims beneficial interest except for any pecuniary interest.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary tax-related disposition by an executive, not a discretionary sale. It slightly reduces direct insider ownership but does not signal a change in company fundamentals or executive confidence.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The filing details a routine, non-discretionary disposition of shares by an insider to cover tax obligations related to RSU vesting. This transaction does not reflect a change in the insider's investment conviction or the company's operational performance, thus it provides no new information to warrant a change in investment recommendation. Investors should hold their position and monitor future operational and financial reports.

Keywords

Fulgent Genetics, FLGT, Insider Transaction, Form 4, Stock Disposition, RSU Vesting, Tax Withholding, Jian Xie